Fisetin and mTOR Inhibition: Autophagy Activation Mechanisms
Expert Summary
Fisetin inhibits PI3K/AKT/mTOR signaling — the same pathway targeted by rapamycin (the most robust life-extension compound in animal models). This results in autophagy induction, reduced protein synthesis, and cell cycle arrest. Unlike rapamycin, fisetin is non-immunosuppressive at supplement doses, making it suitable for long-term use without infection risk.
Key Facts
- mTORC1 inhibition: Fisetin at 20–100 μM concentrations inhibits mTORC1 kinase activity by blocking its upstream activator PI3K and its direct activator AKT. This mimics the primary mechanism of rapamycin's life-extension effects.
- Autophagy induction: mTORC1 suppression releases ULK1 (autophagy initiating kinase) from inhibition, triggering autophagosome formation. Fisetin-treated cells show increased LC3-II levels and autophagosome density — the gold standard autophagy markers.
- Rapamycin comparison: Rapamycin is the gold standard mTOR inhibitor in aging research. Fisetin is approximately 100x less potent than rapamycin at mTORC1 inhibition at equivalent plasma concentrations. However, fisetin adds senolytic activity that rapamycin lacks.
- AMPK activation: Fisetin also activates AMPK (AMP-activated protein kinase), which independently stimulates autophagy via ULK1 phosphorylation. AMPK is the same pathway activated by metformin and berberine.
- Synergy with caloric restriction: Caloric restriction works primarily through mTOR inhibition and AMPK activation — the same pathways as fisetin. Combining fisetin with intermittent fasting may have additive or synergistic autophagy-activating effects.
- Cancer cell selectivity: In cancer cells (which rely heavily on mTOR for proliferation), fisetin's mTOR inhibition is pro-apoptotic. In healthy cells, the effect is autophagic rather than lethal — an important selectivity distinction.
Recommended Products
Frequently Asked Questions
Should I take fisetin with or without food for mTOR inhibition?
Ironically, food (especially protein and carbohydrates) activates mTOR, potentially blunting fisetin's mTOR-inhibitory effects taken simultaneously. For maximal mTOR inhibition, taking fisetin in a fasted or ketogenic state may be preferred. For senolytic activity, however, fat co-administration improves absorption — a trade-off to consider.
Is fisetin a substitute for rapamycin?
No. Fisetin is a mild mTOR modulator; rapamycin is a potent, specific mTOR inhibitor with strong lifespan extension data. Fisetin adds senolytic activity rapamycin lacks, making them complementary rather than interchangeable.
Does fisetin activate autophagy at low doses?
AMPK activation by fisetin occurs at lower concentrations than mTOR inhibition. Low continuous doses (100 mg/day) may activate autophagy via AMPK without significantly inhibiting mTOR.
Scientific References
- Pal HC et al. Fisetin and its role in chronic diseases. Advances in Experimental Medicine and Biology. 2016. PMID: 27815094
- Rath M et al. mTOR and the hallmarks of aging: Pharmacological inhibition of mTOR extends mouse lifespan. Nature Aging. 2021.